Global Health Data Exchange - Discover the World's Health Data

Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF


General Info
Time period covered 
01/2003 - 12/2012